‘Strong ethical reasons’ to consider switching patients on Vectura-linked inhalers

There are strong ethical reasons to consider switching patients with asthma and COPD onto alternative devices after the takeover of inhaler company Vectura by tobacco giant Philip Morris International, UK clinicians have argued. In an article setting out the alternative options to 13 inhalers that use Vectura technology, Professor Nick Hopkinson, Professor of Respiratory Medicine ...

Already a member?

Login to keep reading.

© 2021 the limbic